enniatin J1

Details

Top
Internal ID ab50f4b1-98e1-4af3-852c-3a91f15eef45
Taxonomy Organic acids and derivatives > Peptidomimetics > Depsipeptides > Cyclic depsipeptides
IUPAC Name (3S,6R,9S,12R,15S,18R)-3,4,10,16-tetramethyl-6,9,12,15,18-penta(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone
SMILES (Canonical) CC1C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N1C)C(C)C)C(C)C)C)C(C)C)C(C)C)C)C(C)C
SMILES (Isomeric) C[C@H]1C(=O)O[C@@H](C(=O)N([C@H](C(=O)O[C@@H](C(=O)N([C@H](C(=O)O[C@@H](C(=O)N1C)C(C)C)C(C)C)C)C(C)C)C(C)C)C)C(C)C
InChI InChI=1S/C31H53N3O9/c1-15(2)21-30(39)42-23(17(5)6)26(35)32(12)20(11)29(38)41-24(18(7)8)27(36)33(13)22(16(3)4)31(40)43-25(19(9)10)28(37)34(21)14/h15-25H,1-14H3/t20-,21-,22-,23+,24+,25+/m0/s1
InChI Key IEUFDXNGDNWAKU-MAKNZWJESA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C31H53N3O9
Molecular Weight 611.80 g/mol
Exact Mass 611.37818028 g/mol
Topological Polar Surface Area (TPSA) 140.00 Ų
XlogP 5.60
Atomic LogP (AlogP) 2.52
H-Bond Acceptor 9
H-Bond Donor 0
Rotatable Bonds 5

Synonyms

Top
CHEMBL455737
DTXSID701017631
19893-15-3

2D Structure

Top
2D Structure of enniatin J1

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.5000 50.00%
Caco-2 - 0.6821 68.21%
Blood Brain Barrier + 0.6500 65.00%
Human oral bioavailability + 0.5857 58.57%
Subcellular localzation Mitochondria 0.5190 51.90%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9301 93.01%
OATP1B3 inhibitior + 0.9402 94.02%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.9750 97.50%
BSEP inhibitior - 0.9013 90.13%
P-glycoprotein inhibitior + 0.7034 70.34%
P-glycoprotein substrate - 0.7945 79.45%
CYP3A4 substrate - 0.5775 57.75%
CYP2C9 substrate + 0.5963 59.63%
CYP2D6 substrate - 0.8895 88.95%
CYP3A4 inhibition - 0.9484 94.84%
CYP2C9 inhibition - 0.9077 90.77%
CYP2C19 inhibition - 0.9112 91.12%
CYP2D6 inhibition - 0.9540 95.40%
CYP1A2 inhibition - 0.9384 93.84%
CYP2C8 inhibition - 0.9953 99.53%
CYP inhibitory promiscuity - 0.9883 98.83%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.8007 80.07%
Carcinogenicity (trinary) Non-required 0.6653 66.53%
Eye corrosion - 0.9637 96.37%
Eye irritation - 0.8576 85.76%
Skin irritation - 0.7918 79.18%
Skin corrosion - 0.9433 94.33%
Ames mutagenesis - 0.5600 56.00%
Human Ether-a-go-go-Related Gene inhibition - 0.5528 55.28%
Micronuclear + 0.7300 73.00%
Hepatotoxicity + 0.6551 65.51%
skin sensitisation - 0.9188 91.88%
Respiratory toxicity - 0.5222 52.22%
Reproductive toxicity + 0.6222 62.22%
Mitochondrial toxicity + 0.5337 53.37%
Nephrotoxicity + 0.4899 48.99%
Acute Oral Toxicity (c) III 0.5560 55.60%
Estrogen receptor binding + 0.7257 72.57%
Androgen receptor binding + 0.5282 52.82%
Thyroid receptor binding + 0.5931 59.31%
Glucocorticoid receptor binding - 0.5316 53.16%
Aromatase binding + 0.5300 53.00%
PPAR gamma + 0.5597 55.97%
Honey bee toxicity - 0.8846 88.46%
Biodegradation - 0.8000 80.00%
Crustacea aquatic toxicity - 0.5200 52.00%
Fish aquatic toxicity - 0.8273 82.73%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 95.31% 97.25%
CHEMBL2581 P07339 Cathepsin D 91.07% 98.95%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 88.65% 96.09%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 86.87% 95.56%
CHEMBL1949 P62937 Cyclophilin A 84.96% 98.57%
CHEMBL1907 P15144 Aminopeptidase N 82.66% 93.31%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 82.44% 90.71%
CHEMBL4072 P07858 Cathepsin B 80.45% 93.67%

Cross-Links

Top
PubChem 11814110
NPASS NPC10716
LOTUS LTS0154992
wikiData Q75057331